Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Centre Hospitalier Universitaire Dijon

5 clinical trials · 5 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Centre Hospitalier Universitaire Dijon

RECRUITINGPhase 2NCT05577754

Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With...

This study is a two periods multi-center Phase II trial, with a 6 months double-blind, placebo-controlled period followed by open label period, to assess the efficacy and safety...

Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 2013 locations
Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP)
RECRUITINGNCT03512132

Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy

A number of arguments suggest that the deterioration in high density lipoproteins (HDL) functioning may worsen with the development of nephropathy during type 1 diabetes (T1D)....

Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 2001 location
Type 1 Diabetes
RECRUITINGNCT07256418

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

Scleroderma is a complex connective tissue disease involving three interconnected pathophysiological axes: vascular hyperactivity and remodelling, immune system dysfunction and...

Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 601 location
Scleroderma
RECRUITINGNCT06609668

Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients....

Polymyalgia rheumatica (PMR) is a rheumatologic condition occurring in patients \> 50 years old, characterized by inflammatory pain of the scapular (shoulder) and pelvic (hip)...

Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 781 location
Giant Cell Arteritis (GCA)Polymyalgia Rheumatica (PMR)
RECRUITINGPhase 3NCT06588010

Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary...

Recurrent urinary tract infections (UTIs) in patients with a neurogenic bladder using clean intermittent catheterization (CIC) are a major problem. In this population, urinary...

Sponsor: Centre Hospitalier Universitaire DijonEnrolling: 1101 location
Neurogenic Bladder